279 related articles for article (PubMed ID: 26327765)
1. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
El-Salhy M; Hatlebakk JG; Hausken T
World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH
BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
[TBL] [Abstract][Full Text] [Related]
3. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Vaali K; Dizdar V; Hausken T
Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
[TBL] [Abstract][Full Text] [Related]
4. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.
Mazzawi T; El-Salhy M
Exp Biol Med (Maywood); 2017 Jul; 242(13):1355-1362. PubMed ID: 28737477
[TBL] [Abstract][Full Text] [Related]
5. Endocrine cells in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
World J Gastroenterol; 2014 Mar; 20(9):2383-91. PubMed ID: 24605036
[TBL] [Abstract][Full Text] [Related]
6. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.
El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
Scand J Gastroenterol; 2017 Dec; 52(12):1331-1339. PubMed ID: 28853300
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Mazzawi T; El-Salhy M; Lied GA; Hausken T
Front Cell Infect Microbiol; 2021; 11():524851. PubMed ID: 34055657
[TBL] [Abstract][Full Text] [Related]
8. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Gundersen D; Hausken T
World J Gastrointest Endosc; 2014 May; 6(5):176-85. PubMed ID: 24891930
[TBL] [Abstract][Full Text] [Related]
9. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
[TBL] [Abstract][Full Text] [Related]
10. Stomach antral endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Hatlebakk JG; Hausken T
Int J Mol Med; 2014 Oct; 34(4):967-74. PubMed ID: 25110039
[TBL] [Abstract][Full Text] [Related]
11. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
Mazzawi T; El-Salhy M
Int J Mol Med; 2016 May; 37(5):1247-53. PubMed ID: 26987104
[TBL] [Abstract][Full Text] [Related]
12. Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome.
El-Salhy M; Hausken T; Hatlebakk JG
Mol Med Rep; 2020 Oct; 22(4):3135-3140. PubMed ID: 32945509
[TBL] [Abstract][Full Text] [Related]
13. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome.
El-Salhy M; Hatlebakk JG; Gilja OH; Hausken T
Peptides; 2015 May; 67():12-9. PubMed ID: 25765365
[TBL] [Abstract][Full Text] [Related]
14. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Wendelbo IH; Gundersen D
Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.
El-Salhy M; Gilja OH; Hausken T
Mol Med Rep; 2014 Oct; 10(4):1753-7. PubMed ID: 25109259
[TBL] [Abstract][Full Text] [Related]
16. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome.
Mazzawi T; Hausken T; Gundersen D; El-Salhy M
Eur J Clin Nutr; 2016 Feb; 70(2):175-81. PubMed ID: 26603880
[TBL] [Abstract][Full Text] [Related]
17. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease.
Wendelbo I; Mazzawi T; El-Salhy M
Mol Med Rep; 2014 Jan; 9(1):180-4. PubMed ID: 24213511
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
El-Salhy M; Lomholt-Beck B; Hausken T
Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease.
El-Salhy M; Wendelbo I; Gundersen D
Mol Med Rep; 2013 Aug; 8(2):451-5. PubMed ID: 23778763
[TBL] [Abstract][Full Text] [Related]
20. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.
El-Salhy M; Hausken T; Gilja OH; Hatlebakk JG
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):139-148. PubMed ID: 27927062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
